Solid Biosciences Inc.
Prognozy (mln)
Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
Przychód (średnia) |
1.21 |
1.49 |
3.68 |
35.46 |
131.01 |
298.33 |
Przychód Δ r/r |
0.00% |
22.50% |
147.43% |
863.69% |
269.41% |
127.72% |
Przychód (min) |
1.21 |
1.49 |
3.68 |
35.46 |
131.01 |
298.33 |
Przychód (max) |
1.21 |
1.49 |
3.68 |
35.46 |
131.01 |
298.33 |
EBITDA (średnia) |
0.24 |
0.30 |
0.74 |
7.09 |
26.20 |
59.67 |
EBIT (średnia) |
0.24 |
0.30 |
0.74 |
7.09 |
26.20 |
59.67 |
EBIT % |
20.00% |
20.00% |
20.00% |
20.00% |
20.00% |
20.00% |
Zysk netto (średni) |
-118.83 |
-88.85 |
-83.92 |
-81.17 |
-36.63 |
2.24 |
Zysk netto % |
-9787.86% |
-5974.22% |
-2280.44% |
-228.89% |
-27.96% |
0.75% |
EPS (średnia) |
-2.94 |
-2.18 |
-2.16 |
-1.85 |
-0.90 |
0.06 |
Liczba analityków (Przychody) |
6 |
7 |
10 |
6 |
2 |
5 |
Liczba analityków (EPS) |
10 |
10 |
10 |
6 |
3 |
4 |
symbol |
SLDB |
SLDB |
SLDB |
SLDB |
SLDB |
SLDB |